The 2009 Hamline Law Review Symposium will address "The Food, Drug and Cosmetic Act: Searching for the Crossroads of Safety and Innovation." Topics will include "Prescription Drug and Medical Device Preemption: Where We Are and Where We May Be Headed;" "Congressional Oversight of Supreme Court Preemption Decisions;" Preemption in Pharmaceutical Litigation after Levine;" "Agency Accountability: Federation Preemption's Future;" "Preemption of Product Liability Claims Against Drug and Medical Device Manufacturers;" "FDA Preemption, Wyeth, Congress and a Crystal Ball;" and "Name Brand Exposure for Generic Drug Use: Prescription for Liability."
Presenters include James Beck, counsel, Dechert, LLP; Richard Samp, chief counsel, Washington Legal Foundation; Robert Weiner, partner, Arnold & Porter, LLP; Catherine Sharkey, professor, NYU School of Law; David Prince, professor, William Mitchell College of Law; and David Vladeck, professor, Georgetown University Law Center.
The Law Review Symposium will be held on April 3 at 8:30 a.m.-4:30 at Hamline University, Klas Center. To register, please contact Deb Lange at 651-523-2122 or firstname.lastname@example.org